The overall aim of the CRC for Biomarker Translation is to develop antibodies directed against therapeutic and diagnostic targets (biomarkers) present on cells that play a key role in major diseases, including autoimmune disease (especially rheumatoid arthritis) and cancers (haematological, colorectal, breast and prostate) Please note: This authority is not technically subject to FOI, but you can still make requests to it